185 related articles for article (PubMed ID: 24205241)
1. High-resolution array CGH profiling identifies Na/K transporting ATPase interacting 2 (NKAIN2) as a predisposing candidate gene in neuroblastoma.
Romania P; Castellano A; Surace C; Citti A; De Ioris MA; Sirleto P; De Mariano M; Longo L; Boldrini R; Angioni A; Locatelli F; Fruci D
PLoS One; 2013; 8(10):e78481. PubMed ID: 24205241
[TBL] [Abstract][Full Text] [Related]
2. Germline mutations of the paired-like homeobox 2B (PHOX2B) gene in neuroblastoma.
Trochet D; Bourdeaut F; Janoueix-Lerosey I; Deville A; de Pontual L; Schleiermacher G; Coze C; Philip N; Frébourg T; Munnich A; Lyonnet S; Delattre O; Amiel J
Am J Hum Genet; 2004 Apr; 74(4):761-4. PubMed ID: 15024693
[TBL] [Abstract][Full Text] [Related]
3. BLM germline and somatic PKMYT1 and AHCY mutations: Genetic variations beyond MYCN and prognosis in neuroblastoma.
Novak EM; Halley NS; Gimenez TM; Rangel-Santos A; Azambuja AM; Brumatti M; Pereira PL; Vince CS; Giorgi RR; Bendit I; Cristofani LM; Odone-Filho V
Med Hypotheses; 2016 Dec; 97():22-25. PubMed ID: 27876123
[TBL] [Abstract][Full Text] [Related]
4. Somatic and germline activating mutations of the ALK kinase receptor in neuroblastoma.
Janoueix-Lerosey I; Lequin D; Brugières L; Ribeiro A; de Pontual L; Combaret V; Raynal V; Puisieux A; Schleiermacher G; Pierron G; Valteau-Couanet D; Frebourg T; Michon J; Lyonnet S; Amiel J; Delattre O
Nature; 2008 Oct; 455(7215):967-70. PubMed ID: 18923523
[TBL] [Abstract][Full Text] [Related]
5. PHOX2B mutations and genetic predisposition to neuroblastoma.
Perri P; Bachetti T; Longo L; Matera I; Seri M; Tonini GP; Ceccherini I
Oncogene; 2005 Apr; 24(18):3050-3. PubMed ID: 15735672
[TBL] [Abstract][Full Text] [Related]
6. Methylation-associated PHOX2B gene silencing is a rare event in human neuroblastoma.
de Pontual L; Trochet D; Bourdeaut F; Thomas S; Etchevers H; Chompret A; Minard V; Valteau D; Brugieres L; Munnich A; Delattre O; Lyonnet S; Janoueix-Lerosey I; Amiel J
Eur J Cancer; 2007 Nov; 43(16):2366-72. PubMed ID: 17765533
[TBL] [Abstract][Full Text] [Related]
7. Oligogenic inheritance in neuroblastoma.
Longo L; Tonini GP; Ceccherini I; Perri P
Cancer Lett; 2005 Oct; 228(1-2):65-9. PubMed ID: 15923081
[TBL] [Abstract][Full Text] [Related]
8. Identification of ALK as a major familial neuroblastoma predisposition gene.
Mossé YP; Laudenslager M; Longo L; Cole KA; Wood A; Attiyeh EF; Laquaglia MJ; Sennett R; Lynch JE; Perri P; Laureys G; Speleman F; Kim C; Hou C; Hakonarson H; Torkamani A; Schork NJ; Brodeur GM; Tonini GP; Rappaport E; Devoto M; Maris JM
Nature; 2008 Oct; 455(7215):930-5. PubMed ID: 18724359
[TBL] [Abstract][Full Text] [Related]
9. Identification of GALNT14 as a novel neuroblastoma predisposition gene.
De Mariano M; Gallesio R; Chierici M; Furlanello C; Conte M; Garaventa A; Croce M; Ferrini S; Tonini GP; Longo L
Oncotarget; 2015 Sep; 6(28):26335-46. PubMed ID: 26309160
[TBL] [Abstract][Full Text] [Related]
10. PHOX2B-mediated regulation of ALK expression: in vitro identification of a functional relationship between two genes involved in neuroblastoma.
Bachetti T; Di Paolo D; Di Lascio S; Mirisola V; Brignole C; Bellotti M; Caffa I; Ferraris C; Fiore M; Fornasari D; Chiarle R; Borghini S; Pfeffer U; Ponzoni M; Ceccherini I; Perri P
PLoS One; 2010 Oct; 5(10):. PubMed ID: 20957039
[TBL] [Abstract][Full Text] [Related]
11. ALK germline mutations in patients with neuroblastoma: a rare and weakly penetrant syndrome.
Bourdeaut F; Ferrand S; Brugières L; Hilbert M; Ribeiro A; Lacroix L; Bénard J; Combaret V; Michon J; Valteau-Couanet D; Isidor B; Rialland X; Poirée M; Defachelles AS; Peuchmaur M; Schleiermacher G; Pierron G; Gauthier-Villars M; Janoueix-Lerosey I; Delattre O;
Eur J Hum Genet; 2012 Mar; 20(3):291-7. PubMed ID: 22071890
[TBL] [Abstract][Full Text] [Related]
12. Copy number status and mutation analyses of anaplastic lymphoma kinase (ALK) gene in 90 sporadic neuroblastoma tumors.
Bagci O; Tumer S; Olgun N; Altungoz O
Cancer Lett; 2012 Apr; 317(1):72-7. PubMed ID: 22085494
[TBL] [Abstract][Full Text] [Related]
13. Focal DNA copy number changes in neuroblastoma target MYCN regulated genes.
Kumps C; Fieuw A; Mestdagh P; Menten B; Lefever S; Pattyn F; De Brouwer S; Sante T; Schulte JH; Schramm A; Van Roy N; Van Maerken T; Noguera R; Combaret V; Devalck C; Westermann F; Laureys G; Eggert A; Vandesompele J; De Preter K; Speleman F
PLoS One; 2013; 8(1):e52321. PubMed ID: 23308108
[TBL] [Abstract][Full Text] [Related]
14. cDNA array-CGH profiling identifies genomic alterations specific to stage and MYCN-amplification in neuroblastoma.
Chen QR; Bilke S; Wei JS; Whiteford CC; Cenacchi N; Krasnoselsky AL; Greer BT; Son CG; Westermann F; Berthold F; Schwab M; Catchpoole D; Khan J
BMC Genomics; 2004 Sep; 5():70. PubMed ID: 15380028
[TBL] [Abstract][Full Text] [Related]
15. Genomic coamplification of CDK4/MDM2/FRS2 is associated with very poor prognosis and atypical clinical features in neuroblastoma patients.
Amoroso L; Ognibene M; Morini M; Conte M; Di Cataldo A; Tondo A; D'Angelo P; Castellano A; Garaventa A; Lasorsa VA; Podestà M; Capasso M; Pezzolo A
Genes Chromosomes Cancer; 2020 May; 59(5):277-285. PubMed ID: 31756773
[TBL] [Abstract][Full Text] [Related]
16. Generation of induced pluripotent stem cell lines from two Neuroblastoma patients carrying a germline ALK R1275Q mutation.
Marin Navarro A; Day K; Kogner P; Wilhelm M; Falk A
Stem Cell Res; 2019 Jan; 34():101356. PubMed ID: 30605844
[TBL] [Abstract][Full Text] [Related]
17. Multifocal primary neuroblastoma tumor heterogeneity in siblings with co-occurring PHOX2B and NF1 genetic aberrations.
Rybinski B; Wolinsky T; Brohl A; Moerdler S; Reed DR; Ewart M; Weiser D
Genes Chromosomes Cancer; 2020 Feb; 59(2):119-124. PubMed ID: 31515834
[TBL] [Abstract][Full Text] [Related]
18. Two siblings with familial neuroblastoma with distinct clinical phenotypes harboring an ALK germline mutation.
Kudo K; Ueno H; Sato T; Kubo K; Kanezaki R; Kobayashi A; Kamio T; Sasaki S; Terui K; Kurose A; Yoshida K; Shiozawa Y; Toki T; Ogawa S; Ito E
Genes Chromosomes Cancer; 2018 Dec; 57(12):665-669. PubMed ID: 30350464
[TBL] [Abstract][Full Text] [Related]
19. Genome-wide linkage analysis to identify genetic modifiers of ALK mutation penetrance in familial neuroblastoma.
Devoto M; Specchia C; Laudenslager M; Longo L; Hakonarson H; Maris J; Mossé Y
Hum Hered; 2011; 71(2):135-9. PubMed ID: 21734404
[TBL] [Abstract][Full Text] [Related]
20. A MYCN-amplified cell line derived from a long-term event-free survivor among our sixteen established neuroblastoma cell lines.
Sugimoto T; Gotoh T; Yagyu S; Kuroda H; Iehara T; Hosoi H; Ohta S; Ohira M; Nakagawara A
Cancer Lett; 2013 Apr; 331(1):115-21. PubMed ID: 23268333
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
